SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,125,331,000 | -3.8% | 5,750,582 | -16.5% | 0.93% | -7.6% |
| Q2 2020 | $1,169,803,000 | +35.6% | 6,884,432 | -7.9% | 1.00% | +18.7% |
| Q1 2020 | $862,693,000 | -31.1% | 7,476,972 | -31.7% | 0.85% | -6.8% |
| Q4 2019 | $1,251,343,000 | +10.8% | 10,951,717 | -17.2% | 0.91% | +0.4% |
| Q3 2019 | $1,129,837,000 | +15.3% | 13,229,940 | -6.6% | 0.90% | +24.7% |
| Q2 2019 | $980,278,000 | -6.0% | 14,163,825 | -0.5% | 0.72% | -5.5% |
| Q1 2019 | $1,042,300,000 | +30.1% | 14,231,300 | +0.7% | 0.77% | +18.2% |
| Q4 2018 | $800,900,000 | -28.2% | 14,135,200 | -2.2% | 0.65% | -13.8% |
| Q3 2018 | $1,114,854,000 | +16.0% | 14,456,100 | -0.1% | 0.75% | +5.8% |
| Q2 2018 | $960,929,000 | +27.1% | 14,474,000 | +0.2% | 0.71% | +25.6% |
| Q1 2018 | $755,820,000 | +11.1% | 14,440,582 | +13.6% | 0.57% | +8.6% |
| Q4 2017 | $680,204,000 | -2.2% | 12,714,100 | -0.5% | 0.52% | -9.4% |
| Q3 2017 | $695,329,000 | +3.7% | 12,779,425 | -1.4% | 0.58% | 0.0% |
| Q2 2017 | $670,497,000 | -19.1% | 12,958,975 | -1.7% | 0.58% | -23.4% |
| Q1 2017 | $828,640,000 | +18.7% | 13,182,312 | -0.4% | 0.75% | +9.5% |
| Q4 2016 | $698,156,000 | -3.7% | 13,230,162 | -1.4% | 0.69% | -5.0% |
| Q3 2016 | $724,827,000 | +32.7% | 13,420,237 | -0.7% | 0.72% | +24.2% |
| Q2 2016 | $546,130,000 | +14.5% | 13,514,712 | -0.5% | 0.58% | +17.6% |
| Q1 2016 | $476,845,000 | -17.5% | 13,589,187 | +5.5% | 0.50% | -16.2% |
| Q4 2015 | $578,152,000 | +16.5% | 12,882,175 | +0.1% | 0.59% | +7.3% |
| Q3 2015 | $496,111,000 | -13.9% | 12,865,950 | +8.1% | 0.55% | -2.7% |
| Q2 2015 | $575,916,000 | +37.6% | 11,899,100 | +0.5% | 0.57% | +38.4% |
| Q1 2015 | $418,423,000 | +16.5% | 11,836,575 | +5.9% | 0.41% | +12.4% |
| Q4 2014 | $359,151,000 | -11.8% | 11,178,050 | +2.0% | 0.36% | -16.5% |
| Q3 2014 | $407,303,000 | -2.3% | 10,954,900 | +0.5% | 0.44% | -4.4% |
| Q2 2014 | $416,764,000 | -16.9% | 10,895,800 | -1.0% | 0.46% | -19.7% |
| Q1 2014 | $501,479,000 | +14.8% | 11,007,005 | +0.5% | 0.57% | +8.2% |
| Q4 2013 | $436,931,000 | -8.4% | 10,953,400 | +0.6% | 0.52% | -16.4% |
| Q3 2013 | $477,177,000 | +39.3% | 10,887,000 | -0.0% | 0.63% | +28.2% |
| Q2 2013 | $342,534,000 | – | 10,887,919 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |